KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Payables (2016 - 2025)

Historic Payables for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $28.1 million.

  • Medpace Holdings' Payables fell 1348.38% to $28.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $28.1 million, marking a year-over-year decrease of 1348.38%. This contributed to the annual value of $28.1 million for FY2025, which is 1348.38% down from last year.
  • Per Medpace Holdings' latest filing, its Payables stood at $28.1 million for Q4 2025, which was down 1348.38% from $26.5 million recorded in Q3 2025.
  • In the past 5 years, Medpace Holdings' Payables registered a high of $278.5 million during Q2 2022, and its lowest value of $21.3 million during Q1 2021.
  • Its 5-year average for Payables is $61.1 million, with a median of $28.6 million in 2023.
  • In the last 5 years, Medpace Holdings' Payables soared by 109394.67% in 2022 and then crashed by 8395.77% in 2024.
  • Quarter analysis of 5 years shows Medpace Holdings' Payables stood at $25.7 million in 2021, then soared by 223.5% to $83.1 million in 2022, then tumbled by 61.64% to $31.9 million in 2023, then rose by 2.07% to $32.5 million in 2024, then decreased by 13.48% to $28.1 million in 2025.
  • Its last three reported values are $28.1 million in Q4 2025, $26.5 million for Q3 2025, and $43.3 million during Q2 2025.